Mechanistic insights explain the transforming potential of the T507K substitution in the protein-tyrosine phosphatase SHP2
Abstract
The protein-tyrosine phosphatase SHP2 is an allosteric enzyme critical for cellular events downstream of growth factor receptors. Mutations in the SHP2 gene have been linked to many different types of human diseases, including developmental disorders, leukemia, and solid tumors. Unlike most SHP2-activating mutations, the T507K substitution in SHP2 is unique in that it exhibits oncogenic Ras-like transforming activity. However, the biochemical basis of how the SHP2/T507K variant elicits transformation remains unclear. By combining kinetic and biophysical methods, X-ray crystallography, and molecular modeling, as well as using cell biology approaches, in this work we uncovered that the T507K substitution alters both SHP2 substrate specificity and its allosteric regulatory mechanism. We found that although SHP2/T507K exists in the closed, autoinhibited conformation similar to the WT enzyme, the interactions between its N-SH2 and protein-tyrosine phosphatase domains are weakened such that SHP2/T507K possesses a higher affinity for the scaffolding protein Grb2-associated binding protein 1 (Gab1). We also discovered that the T507K substitution alters the structure of the SHP2 active site, resulting in a change in SHP2 substrate preference for Sprouty1, a known negative regulator of Ras signaling and a potential tumor suppressor. Our results suggest that SHP2/T507K's shift in substrate specificity coupled with itsmore »
- Publication Date:
- Research Org.:
- Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
- Sponsoring Org.:
- National Institutes of Health (NIH)
- OSTI Identifier:
- 1630331
- Grant/Contract Number:
- RO1 CA069202; RO1 CA207288
- Resource Type:
- Accepted Manuscript
- Journal Name:
- Journal of Biological Chemistry
- Additional Journal Information:
- Journal Volume: 295; Journal Issue: 18; Journal ID: ISSN 0021-9258
- Publisher:
- American Society for Biochemistry and Molecular Biology
- Country of Publication:
- United States
- Language:
- ENGLISH
- Subject:
- 59 BASIC BIOLOGICAL SCIENCES; 37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CHEMISTRY; phosphatase; cancer; transformation; structure–function; kinetics; signaling; mutation; SHP2
Citation Formats
Zhang, Ruo-Yu, Yu, Zhi-Hong, Chen, Lan, Walls, Chad D., Zhang, Sheng, Wu, Li, and Zhang, Zhong-Yin. Mechanistic insights explain the transforming potential of the T507K substitution in the protein-tyrosine phosphatase SHP2. United States: N. p., 2020.
Web. doi:10.1074/jbc.RA119.010274.
Zhang, Ruo-Yu, Yu, Zhi-Hong, Chen, Lan, Walls, Chad D., Zhang, Sheng, Wu, Li, & Zhang, Zhong-Yin. Mechanistic insights explain the transforming potential of the T507K substitution in the protein-tyrosine phosphatase SHP2. United States. https://doi.org/10.1074/jbc.RA119.010274
Zhang, Ruo-Yu, Yu, Zhi-Hong, Chen, Lan, Walls, Chad D., Zhang, Sheng, Wu, Li, and Zhang, Zhong-Yin. Wed .
"Mechanistic insights explain the transforming potential of the T507K substitution in the protein-tyrosine phosphatase SHP2". United States. https://doi.org/10.1074/jbc.RA119.010274. https://www.osti.gov/servlets/purl/1630331.
@article{osti_1630331,
title = {Mechanistic insights explain the transforming potential of the T507K substitution in the protein-tyrosine phosphatase SHP2},
author = {Zhang, Ruo-Yu and Yu, Zhi-Hong and Chen, Lan and Walls, Chad D. and Zhang, Sheng and Wu, Li and Zhang, Zhong-Yin},
abstractNote = {The protein-tyrosine phosphatase SHP2 is an allosteric enzyme critical for cellular events downstream of growth factor receptors. Mutations in the SHP2 gene have been linked to many different types of human diseases, including developmental disorders, leukemia, and solid tumors. Unlike most SHP2-activating mutations, the T507K substitution in SHP2 is unique in that it exhibits oncogenic Ras-like transforming activity. However, the biochemical basis of how the SHP2/T507K variant elicits transformation remains unclear. By combining kinetic and biophysical methods, X-ray crystallography, and molecular modeling, as well as using cell biology approaches, in this work we uncovered that the T507K substitution alters both SHP2 substrate specificity and its allosteric regulatory mechanism. We found that although SHP2/T507K exists in the closed, autoinhibited conformation similar to the WT enzyme, the interactions between its N-SH2 and protein-tyrosine phosphatase domains are weakened such that SHP2/T507K possesses a higher affinity for the scaffolding protein Grb2-associated binding protein 1 (Gab1). We also discovered that the T507K substitution alters the structure of the SHP2 active site, resulting in a change in SHP2 substrate preference for Sprouty1, a known negative regulator of Ras signaling and a potential tumor suppressor. Our results suggest that SHP2/T507K's shift in substrate specificity coupled with its preferential association of SHP2/T507K with Gab1 enable the mutant SHP2 to more efficiently dephosphorylate Sprouty1 at pTyr-53. This dephosphorylation hyperactivates Ras signaling, which is likely responsible for SHP2/T507K's Ras-like transforming activity.},
doi = {10.1074/jbc.RA119.010274},
journal = {Journal of Biological Chemistry},
number = 18,
volume = 295,
place = {United States},
year = {Wed Mar 18 00:00:00 EDT 2020},
month = {Wed Mar 18 00:00:00 EDT 2020}
}
Free Publicly Available Full Text
Publisher's Version of Record
Other availability
Search WorldCat to find libraries that may hold this journal
Cited by: 6 works
Citation information provided by
Web of Science
Web of Science
Save to My Library
You must Sign In or Create an Account in order to save documents to your library.
Works referenced in this record:
Therapeutic Targeting of Oncogenic Tyrosine Phosphatases
journal, August 2017
- Frankson, Rochelle; Yu, Zhi-Hong; Bai, Yunpeng
- Cancer Research, Vol. 77, Issue 21
The Somatic Genomic Landscape of Glioblastoma
journal, October 2013
- Brennan, Cameron W.; Verhaak, Roel G. W.; McKenna, Aaron
- Cell, Vol. 155, Issue 2
Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: A paradigm for inhibitor design
journal, December 1997
- Puius, Y. A.; Zhao, Y.; Sullivan, M.
- Proceedings of the National Academy of Sciences, Vol. 94, Issue 25
Molecular Basis of Gain-of-Function LEOPARD Syndrome-Associated SHP2 Mutations
journal, June 2014
- Yu, Zhi-Hong; Zhang, Ruo-Yu; Walls, Chad D.
- Biochemistry, Vol. 53, Issue 25
Point mutations in the abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo.
journal, February 1992
- Mayer, B. J.; Jackson, P. K.; Van Etten, R. A.
- Molecular and Cellular Biology, Vol. 12, Issue 2
Expression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomas
journal, March 2009
- Frank, Matthew J.; Dawson, David W.; Bensinger, Steven J.
- Blood, Vol. 113, Issue 11
Measuring Ras-family GTP levels in vivo—running hot and cold
journal, October 2005
- Castro, Ariel F.; Rebhun, John F.; Quilliam, Lawrence A.
- Methods, Vol. 37, Issue 2
Protein Analysis by Hydrogen Exchange Mass Spectrometry
journal, June 2003
- Hoofnagle, Andrew N.; Resing, Katheryn A.; Ahn, Natalie G.
- Annual Review of Biophysics and Biomolecular Structure, Vol. 32, Issue 1
The Expression of Sprouty1, an Inhibitor of Fibroblast Growth Factor Signal Transduction, Is Decreased in Human Prostate Cancer
journal, July 2004
- Kwabi-Addo, Bernard; Wang, Jianghua; Erdem, Halime
- Cancer Research, Vol. 64, Issue 14
Sprouty 2, an Inhibitor of Mitogen-Activated Protein Kinase Signaling, Is Down-Regulated in Hepatocellular Carcinoma
journal, February 2006
- Fong, Chee Wai; Chua, Mei-Sze; McKie, Arthur B.
- Cancer Research, Vol. 66, Issue 4
Sprouty2 regulates growth and differentiation of human neuroblastoma cells through RET tyrosine kinase
journal, June 2007
- Ishida, Maki; Ichihara, Masatoshi; Mii, Shinji
- Cancer Science, Vol. 98, Issue 6
Molecular Mechanism for a Role of SHP2 in Epidermal Growth Factor Receptor Signaling
journal, November 2003
- Agazie, Yehenew M.; Hayman, Michael J.
- Molecular and Cellular Biology, Vol. 23, Issue 21
Regulatory Mechanisms and Novel Therapeutic Targeting Strategies for Protein Tyrosine Phosphatases
journal, May 2017
- Yu, Zhi-Hong; Zhang, Zhong-Yin
- Chemical Reviews, Vol. 118, Issue 3
Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase
journal, May 1994
- Lee, Chi-Hon; Kominos, Dorothea; Jacques, Steven
- Structure, Vol. 2, Issue 5
SHP2 sails from physiology to pathology
journal, October 2015
- Tajan, Mylène; de Rocca Serra, Audrey; Valet, Philippe
- European Journal of Medical Genetics, Vol. 58, Issue 10
Structural and Mechanistic Insights into LEOPARD Syndrome-Associated SHP2 Mutations
journal, March 2013
- Yu, Zhi-Hong; Xu, Jie; Walls, Chad D.
- Journal of Biological Chemistry, Vol. 288, Issue 15
Sprouty1 is a candidate tumor-suppressor gene in medullary thyroid carcinoma
journal, December 2011
- Macià, A.; Gallel, P.; Vaquero, M.
- Oncogene, Vol. 31, Issue 35
The Amber biomolecular simulation programs
journal, January 2005
- Case, David A.; Cheatham, Thomas E.; Darden, Tom
- Journal of Computational Chemistry, Vol. 26, Issue 16
Sprouty proteins are in vivo targets of Corkscrew/SHP-2 tyrosine phosphatases
journal, February 2006
- Jarvis, L. A.
- Development, Vol. 133, Issue 6
Activating Mutations of the Noonan Syndrome-Associated SHP2/PTPN11 Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia
journal, December 2004
- Bentires-Alj, Mohamed; Paez, J. Guillermo; David, Frank S.
- Cancer Research, Vol. 64, Issue 24
Structural and Evolutionary Relationships among Protein Tyrosine Phosphatase Domains
journal, November 2001
- Andersen, J. N.; Mortensen, O. H.; Peters, G. H.
- Molecular and Cellular Biology, Vol. 21, Issue 21
The Ras/Mitogen-Activated Protein Kinase Pathway Inhibitor and Likely Tumor Suppressor Proteins, Sprouty 1 and Sprouty 2 Are Deregulated in Breast Cancer
journal, September 2004
- Lo, Ting Ling; Yusoff, Permeen; Fong, Chee Wai
- Cancer Research, Vol. 64, Issue 17
Requirement of SHP2 Binding to Grb2-associated Binder-1 for Mitogen-activated Protein Kinase Activation in Response to Lysophosphatidic Acid and Epidermal Growth Factor
journal, April 2000
- Cunnick, Jess M.; Dorsey, Jay F.; Munoz-Antonia, Teresita
- Journal of Biological Chemistry, Vol. 275, Issue 18
Sprouty genes function in suppression of prostate tumorigenesis
journal, November 2012
- Schutzman, J. L.; Martin, G. R.
- Proceedings of the National Academy of Sciences, Vol. 109, Issue 49
Phosphotyrosines 627 and 659 of Gab1 Constitute a Bisphosphoryl Tyrosine-based Activation Motif (BTAM) Conferring Binding and Activation of SHP2
journal, April 2001
- Cunnick, Jess M.; Mei, Lin; Doupnik, Craig A.
- Journal of Biological Chemistry, Vol. 276, Issue 26
Structural Basis for Substrate Specificity of Protein-tyrosine Phosphatase SHP-1
journal, February 2000
- Yang, Jian; Cheng, Zhiliang; Niu, Tianqi
- Journal of Biological Chemistry, Vol. 275, Issue 6
Isolation of a distinct class of gain-of-function SHP-2 mutants with oncogenic RAS-like transforming activity from solid tumors
journal, January 2008
- Miyamoto, D.; Miyamoto, M.; Takahashi, A.
- Oncogene, Vol. 27, Issue 25
PHENIX: a comprehensive Python-based system for macromolecular structure solution
journal, January 2010
- Adams, Paul D.; Afonine, Pavel V.; Bunkóczi, Gábor
- Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2, p. 213-221
Visualization of the Cysteinyl-phosphate Intermediate of a Protein-tyrosine Phosphatase by X-ray Crystallography
journal, April 1998
- Pannifer, Andrew D. B.; Flint, Andrew J.; Tonks, Nicholas K.
- Journal of Biological Chemistry, Vol. 273, Issue 17
Mechanism of activating mutations and allosteric drug inhibition of the phosphatase SHP2
journal, October 2018
- Pádua, Ricardo A. P.; Sun, Yizhi; Marko, Ingrid
- Nature Communications, Vol. 9, Issue 1
Structural reorganization of SHP2 by oncogenic mutations and implications for oncoprotein resistance to allosteric inhibition
journal, October 2018
- LaRochelle, Jonathan R.; Fodor, Michelle; Vemulapalli, Vidyasiri
- Nature Communications, Vol. 9, Issue 1
Altering the Nucleophile Specificity of a Protein-tyrosine Phosphatase-catalyzed Reaction: PROBING THE FUNCTION OF THE INVARIANT GLUTAMINE RESIDUES
journal, March 1998
- Zhao, Yu; Wu, Li; Noh, Seong J.
- Journal of Biological Chemistry, Vol. 273, Issue 10
Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway
journal, October 2002
- Hanafusa, Hiroshi; Torii, Satoru; Yasunaga, Takayuki
- Nature Cell Biology, Vol. 4, Issue 11
Sprouty-related Ena/Vasodilator-stimulated Phosphoprotein Homology 1-Domain-containing Protein (SPRED1), a Tyrosine-Protein Phosphatase Non-receptor Type 11 (SHP2) Substrate in the Ras/Extracellular Signal-regulated Kinase (ERK) Pathway
journal, April 2011
- Quintanar-Audelo, Martina; Yusoff, Permeen; Sinniah, Saravanan
- Journal of Biological Chemistry, Vol. 286, Issue 26
Shp2, an SH2-containing Protein-tyrosine Phosphatase, Positively Regulates Receptor Tyrosine Kinase Signaling by Dephosphorylating and Inactivating the Inhibitor Sprouty
journal, March 2004
- Hanafusa, Hiroshi; Torii, Satoru; Yasunaga, Takayuki
- Journal of Biological Chemistry, Vol. 279, Issue 22
NMRPipe: A multidimensional spectral processing system based on UNIX pipes
journal, November 1995
- Delaglio, Frank; Grzesiek, Stephan; Vuister, GeertenW.
- Journal of Biomolecular NMR, Vol. 6, Issue 3
Functional Effects of PTPN11 (SHP2) Mutations Causing LEOPARD Syndrome on Epidermal Growth Factor-Induced Phosphoinositide 3-Kinase/AKT/Glycogen Synthase Kinase 3β Signaling
journal, March 2010
- Edouard, Thomas; Combier, Jean-Philippe; Nédélec, Audrey
- Molecular and Cellular Biology, Vol. 30, Issue 10
The ‘Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling
journal, June 2003
- Neel, Benjamin G.; Gu, Haihua; Pao, Lily
- Trends in Biochemical Sciences, Vol. 28, Issue 6
Hydrogen exchange mass spectrometry for the analysis of protein dynamics
journal, January 2005
- Wales, Thomas E.; Engen, John R.
- Mass Spectrometry Reviews, Vol. 25, Issue 1
A Continuous Spectrophotometric and Fluorometric Assay for Protein Tyrosine Phosphatase Using Phosphotyrosine-Containing Peptides
journal, May 1993
- Zhang, Z. Y.; Maclean, D.; Thiemesefler, A. M.
- Analytical Biochemistry, Vol. 211, Issue 1
Spred is a Sprouty-related suppressor of Ras signalling
journal, August 2001
- Wakioka, Toru; Sasaki, Atsuo; Kato, Reiko
- Nature, Vol. 412, Issue 6847
MOLREP an Automated Program for Molecular Replacement
journal, December 1997
- Vagin, A.; Teplyakov, A.
- Journal of Applied Crystallography, Vol. 30, Issue 6, p. 1022-1025
Semi-automated data processing of hydrogen exchange mass spectra using HX-Express
journal, December 2006
- Weis, David D.; Engen, John R.; Kass, Ignatius J.
- Journal of the American Society for Mass Spectrometry, Vol. 17, Issue 12
UCSF Chimera?A visualization system for exploratory research and analysis
journal, January 2004
- Pettersen, Eric F.; Goddard, Thomas D.; Huang, Conrad C.
- Journal of Computational Chemistry, Vol. 25, Issue 13
Roles of Gab1 and SHP2 in Paxillin Tyrosine Dephosphorylation and Src Activation in Response to Epidermal Growth Factor
journal, December 2003
- Ren, Yuan; Meng, Songshu; Mei, Lin
- Journal of Biological Chemistry, Vol. 279, Issue 9
Crystal Structure of the Tyrosine Phosphatase SHP-2
journal, February 1998
- Hof, Peter; Pluskey, Scott; Dhe-Paganon, Sirano
- Cell, Vol. 92, Issue 4
Activation of the SH2-containing protein tyrosine phosphatase, SH-PTP2, by phosphotyrosine-containing peptides derived from insulin receptor substrate-1.
journal, May 1994
- Sugimoto, S.; Wandless, T. J.; Shoelson, S. E.
- Journal of Biological Chemistry, Vol. 269, Issue 18
[20] Processing of X-ray diffraction data collected in oscillation mode
book, January 1997
- Otwinowski, Zbyszek; Minor, Wladek
- Macromolecular Crystallography Part A, 307-326